251 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
INCY Incyte Corporation $67.04 $14.25B N/A
Article Searches
Concert Pharma's CTP-692 Positive for Schizophrenia in Phase I http://www.zacks.com/stock/news/429331/concert-pharmas-ctp-692-positive-for-schizophrenia-in-phase-i?cid=CS-ZC-FT-429331 Jun 13, 2019 - Concert Pharma (CNCE) reports favorable data from the two early-stage studies on its pipeline candidate, CTP-692, currently under evaluation as an adjunctive treatment for schizophrenia. Share rise.
Merck's Keytruda Wins FDA Nod for First-Line Head/Neck Cancer http://www.zacks.com/stock/news/428338/mercks-keytruda-wins-fda-nod-for-first-line-head-neck-cancer?cid=CS-ZC-FT-428338 Jun 12, 2019 - Merck's (MRK) Keytruda is already approved for use in 15 cancer indications across 10 different tumor types in the United States.
Incyte Begins Phase III Study for Treatment of Duct Cancer http://www.zacks.com/stock/news/425849/incyte-begins-phase-iii-study-for-treatment-of-duct-cancer?cid=CS-ZC-FT-425849 Jun 06, 2019 - Incyte (INCY) begins first phase III study of pemigatinib as a first-line therapy for patients with metastatic or surgically unresectable cholangiocarcinoma.
Celgene (CELG) Presents Data on Pipeline Candidates at ASCO http://www.zacks.com/stock/news/424905/celgene-celg-presents-data-on-pipeline-candidates-at-asco?cid=CS-ZC-FT-424905 Jun 05, 2019 - Celgene (CELG) presents data on myelofibrosis candidate from a phase II study and an oncology candidate at ASCO.
Novartis (NVS) Announces Various Data Presentations at ASCO http://www.zacks.com/stock/news/424089/novartis-nvs-announces-various-data-presentations-at-asco?cid=CS-ZC-FT-424089 Jun 03, 2019 - Novartis (NVS) announces a number of data presentations at the ASCO 2019 annual meeting.
Mesoblast Starts Rolling BLA Submission for Remestemcel-L http://www.zacks.com/stock/news/422489/mesoblast-starts-rolling-bla-submission-for-remestemcel-l?cid=CS-ZC-FT-422489 May 30, 2019 - Mesoblast (MESO) begins the rolling submission of a BLA for its lead product, candidate remestemcel-L, to the FDA for treating children with steroid-refractory acute graft versus host disease.
Biotech Stock Roundup: AMGN's Nuevolution Buyout, CELG, INCY Drugs' Label Expansion http://www.zacks.com/stock/news/421467/biotech-stock-roundup-amgns-nuevolution-buyout-celg-incy-drugs-label-expansion?cid=CS-ZC-FT-421467 May 29, 2019 - Key highlights of the past week include regulatory approvals, collaborations and pipeline updates.
Incyte (INCY) Receives FDA Nod for Label Expansion of Jakafi http://www.zacks.com/stock/news/420060/incyte-incy-receives-fda-nod-for-label-expansion-of-jakafi?cid=CS-ZC-FT-420060 May 27, 2019 - Incyte (INCY) obtains FDA approval for a third indication of lead drug, Jakafi, for the treatment of GVHD.
Top Stock Reports for Medtronic, TJX Companies & Deere http://www.zacks.com/research-daily/419127/top-stock-reports-for-medtronic-tjx-companies-deere?cid=CS-ZC-FT-419127 May 24, 2019 - Top Stock Reports for Medtronic, TJX Companies & Deere
Biotech Stock Roundup: BIIB, VRTX, ALXN Q1 Earnings Top & Other Pipeline Updates http://www.zacks.com/stock/news/406790/biotech-stock-roundup-biib-vrtx-alxn-q1-earnings-top-other-pipeline-updates?cid=CS-ZC-FT-406790 May 01, 2019 - Key highlights of the past week are earnings releases by most leading biotech entities.

Pages: 123456...26

Page 1>